Contributions of different modules of the plasminogen-binding Streptococcus pyogenes M-protein that mediate its

Cunjia Qiu1, Yue Yuan2, Jaroslav Zajicek1

  • 1W.M. Keck Center for Transgene Research, University of Notre Dame, Notre Dame, IN 46556, United States; Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN 46556, United States.

Insights

Group A Streptococcus pyogenes M-protein (PAM) structure was investigated. Dimerization depends on conserved C-terminal domains, while N-terminal domains retain human plasminogen binding, crucial for GAS virulence.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Structural Biology

Background:

  • Group A Streptococcus pyogenes (GAS) causes human infections.
  • M-protein (M-Prt) is a key GAS virulence factor.
  • Specific M-Prt variants (PAM) bind human plasminogen (hPg), aiding GAS survival.

Purpose of the Study:

  • Investigate structure-function relationships of PAM-type M-Prts.
  • Identify PAM dimerization determinants.
  • Understand how sequence variations affect PAM structure and function.

Main Methods:

  • Bioinformatic analysis of PAM sequences.
  • Biophysical characterization of PAM variants and truncated versions.
  • Structural modeling of PAM secondary and quaternary structures.

Main Results:

  • Dimerization of PAM involves distinct domain contributions.
  • Conserved C-terminal C-D domains are critical for PAM dimerization.
  • Variable N-terminal A-domains maintain hPg and plasmin binding capacity.

Conclusions:

  • Proposed an experimentally-based model for PAM structure.
  • PAM structure is modular, with conserved domains driving dimerization.
  • N-terminal variability does not impede essential host factor binding for virulence.

Related Concept Videos

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
912
Structural Protein Function01:56

Structural Protein Function

Structural proteins are a category of proteins responsible for functions ranging from cell shape and movement to providing support to major structures such as bones, cartilage, hair, and muscles. This group includes proteins such as collagen, actin, myosin, and keratin.
Collagen, the most abundant protein in mammals, is found throughout the body. In connective tissue, such as skin, ligaments, and tendons, it provides tensile strength and elasticity.  In bones and teeth, it mineralizes to...
30.0K
Cooperative Binding of Transcription Regulators02:13

Cooperative Binding of Transcription Regulators

Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome.  Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form...
7.4K
Mechanical Protein Functions01:58

Mechanical Protein Functions

Proteins perform many mechanical functions in a cell. These proteins can be classified into two general categories- proteins that generate mechanical forces and proteins that are subjected to mechanical forces. Proteins providing mechanical support to the structure of the cell, such as keratin, are subjected to mechanical force, whereas proteins involved in cell movement and transport of molecules across cell membranes, such as an ion pump, are examples of generating mechanical force. 
5.6K
Protein-protein Interfaces02:04

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.7K
Factors Affecting Protein-Drug Binding: Protein-Related Factors01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
574